Home
BCTX
BCTX News

Latest BriaCell Therapeutics Corp. (BCTX) News on November 22, 2025

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

GlobeNewswire

2 days ago

BriaCell and Receptor.AI to Collaborate on AI Driven Small Molecule Cancer Therapeutics

MT Newswires

3 days ago

BriaCell Therapeutics Selected to Present Four Posters at Breast Cancer Symposium

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

GlobeNewswire

4 days ago

BriaCell Selected to Present Phase 2 & 3 Clinical Data at SABCS® 2025

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

GlobeNewswire

15 days ago

BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ at SITC 2025

MT Newswires

18 days ago

BriaCell Therapeutics to Present Latest Anti-cancer Data of Bria-OTS+

Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding

Zacks

25 days ago

Zacks.com featured highlights include Groupon, BriaCell Therapeutics and InnovAge Holding

Top 3 Earnings Acceleration Buys for November

Zacks

25 days ago

Top 3 Earnings Acceleration Buys for November

MT Newswires

a month ago

BriaCell Receives Data Safety Monitoring Board OK to Continue Phase 3 Metastatic Breast Cancer Study

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

a month ago

BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer

MT Newswires

a month ago

BriaCell Adds Three Cancer Centres to Phase 3 Study, Works With MSK Accelerator to Advance Bria-OTS+

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

GlobeNewswire

a month ago

BriaCell Adds Key Clinical Sites in Phase 3 Metastatic Breast Cancer Study

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

GlobeNewswire

a month ago

BriaCell Announces Collaboration with MSK Accelerator to Advance Bria-OTS+™ for Breast Cancer

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

GlobeNewswire

a month ago

BriaCell to Present Positive Clinical Biomarker Data of Phase 3 Study at ESMO 2025

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

GlobeNewswire

2 months ago

BriaCell to Present Bria-OTS+™ Preclinical Data at SITC 2025 Annual Meeting

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

GlobeNewswire

3 months ago

BriaCell Selected for MSK’s 2025 Therapeutics Accelerator Program for Bria-OTS+™ for Cancer

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

Simply Wall St.

5 months ago

Here's Why We're A Bit Worried About BriaCell Therapeutics' (TSE:BCT) Cash Burn Situation

MT Newswires

5 months ago

BriaCell Up in U.S. Pre-market, as Data Safety Board Review Recommends Phase 3 Study Continues

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

5 months ago

BriaCell Announces Positive Recommendation from Data Safety Monitoring Board for Pivotal Phase 3 Study in Metastatic Breast Cancer

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

GlobeNewswire

6 months ago

BriaCell Announces Virtual Investor Presentations on Thursday, June 12 and Thursday, June 26

MT Newswires

6 months ago

BriaCell Reports "Robust" Overall Survival and Clinical Benefit Data at ASCO 2025

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

GlobeNewswire

6 months ago

BriaCell Reports Robust Overall Survival and Clinical Benefit Data at ASCO 2025

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

GOBankingRates

6 months ago

7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs

3 International Vacations That Are Cheaper Than an iPhone

GOBankingRates

6 months ago

3 International Vacations That Are Cheaper Than an iPhone

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

GOBankingRates

6 months ago

Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck

This week in Trumponomics: Too bad TACO isn’t true

Yahoo Finance

6 months ago

This week in Trumponomics: Too bad TACO isn’t true

Starmer says Farage would spook the City and give us Truss 2 – he could be right

The Guardian

6 months ago

Starmer says Farage would spook the City and give us Truss 2 – he could be right

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Yahoo Finance Video

6 months ago

AI ecosystem isn't just Nvidia: Unlock it further with this ETF

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Benzinga

6 months ago

Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?

Ford recalls more than 29,000 vehicles in the US, NHTSA says

Reuters

6 months ago

Ford recalls more than 29,000 vehicles in the US, NHTSA says

MT Newswires

6 months ago

BriaCell Down More Than 2% Even As Says Bria-OTS Phase 1/2 Study Clears Safety Evaluation; First Patient Dosed

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

GlobeNewswire

6 months ago

BriaCell Bria-OTS™ Phase 1/2 Study Clears Safety Evaluation; Doses First Patient in Combination with Checkpoint Inhibitor

MT Newswires

6 months ago

BriaCell to Showcase Survival and Clinical Benefit Data at ASCO Meeting Next Week

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

GlobeNewswire

6 months ago

BriaCell Abstracts Showcase Positive Survival and Clinical Benefit Data at ASCO 2025

BriaCell CEO Letter to Shareholders

GlobeNewswire

6 months ago

BriaCell CEO Letter to Shareholders

GlobeNewswire

7 months ago

BriaCell Reports “Late-Breaker” Phase 3 Data at AACR 2025: Positive Tolerability Profile and Potential Response Biomarkers Identified

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Closing of $13.8 million Public Offering

MT Newswires

7 months ago

BriaCell Therapeutics Lower, Says Presenting Positive Phase 2 Data at AACR

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

GlobeNewswire

7 months ago

BriaCell Presents Benchmark Beating Survival and Clinical Benefit at AACR 2025; Advancements in Next Generation Bria-OTS+™ Development

MT Newswires

7 months ago

BriaCell Therapeutics to Raise $13.8 Million in Public Offering; Shares Fall

MT Newswires

7 months ago

BriaCell Therapeutics Down 17% In US Premarket As Prices US$13.8 Million Public Offering

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

GlobeNewswire

7 months ago

BriaCell Therapeutics Announces Pricing of $13.8 million Public Offering

MT Newswires

7 months ago

Update: BriaCell Jumps More Than 30% As Reports Complete Lung Metastasis Resolution in Patient

MT Newswires

7 months ago

BriaCell Jumps 41% in U.S. Pre-market Trading, Reports Complete Lung Metastasis Resolution in Patient

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

GlobeNewswire

7 months ago

BriaCell Confirms 100% Resolution of Lung Metastasis with Bria-OTS™

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

GlobeNewswire

7 months ago

BriaCell Announces Four Clinical Data Presentations at ASCO 2025

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

GlobeNewswire

7 months ago

BriaCell Enrollment Pace Accelerating in Phase 3 Clinical Study in Advanced Metastatic Breast Cancer (Bria-ABC)

MT Newswires

7 months ago

BriaCell Therapeutics Up 7% as It Reports Latest Survival Data From Phase 2 Breast Cancer Study

MT Newswires

7 months ago

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday

MT Newswires

7 months ago

BriaCell Says Breast Cancer Therapy Shows Positive Survival Data; Shares Rise

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

GlobeNewswire

7 months ago

BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer

MT Newswires

7 months ago

BriaCell Subsidiary Develops Antibodies to Anti-Cancer Target B7-H3

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

GlobeNewswire

7 months ago

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

GlobeNewswire

8 months ago

BriaCell to Present Clinical and Preclinical Data at the 2025 AACR Conference

MT Newswires

8 months ago

BriaCell Therapeutics Says Data Safety Monitoring Board Recommends Continuation of Phase 3 Trial in Metastatic Breast Cancer

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

8 months ago

Second Data Safety Monitoring Board Issues Positive Recommendation to Continue BriaCell’s Phase 3 Study in Metastatic Breast Cancer

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Zacks

9 months ago

BRIACELL THERAP (BCTX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewswire

10 months ago

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

BriaCell Therapeutics Announces Closing of Public Offering

GlobeNewswire

10 months ago

BriaCell Therapeutics Announces Closing of Public Offering

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

Zacks

10 months ago

BRIACELL THERAP (BCTX) Upgraded to Buy: What Does It Mean for the Stock?

MT Newswires

10 months ago

Top Premarket Decliners

BriaCell Therapeutics Announces Pricing of Public Offering

GlobeNewswire

10 months ago

BriaCell Therapeutics Announces Pricing of Public Offering

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

GlobeNewswire

10 months ago

BriaCell Therapeutics Announces Proposed Public Offering of Common Shares

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

GlobeNewswire

10 months ago

BriaCell Announces Resolution of Lung Metastasis in First Patient treated with Bria-OTS™

MT Newswires

10 months ago

BriaCell Therapeutics Completes 15:1 Share Consolidation

BriaCell Announces Completion of 15:1 Share Consolidation

GlobeNewswire

10 months ago

BriaCell Announces Completion of 15:1 Share Consolidation

BriaCell Announces Proposed Effective Date of Share Consolidation

GlobeNewswire

a year ago

BriaCell Announces Proposed Effective Date of Share Consolidation

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

GlobeNewswire

a year ago

BriaCell Announces Rescheduling of its Annual General Meeting of Shareholders to February 5, 2025

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

Simply Wall St.

a year ago

Insider Purchases Worth US$5.52m See Losses As BriaCell Therapeutics Market Value Drops To CA$40m

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

a year ago

BriaCell Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

GlobeNewswire

a year ago

BriaPro Therapeutics Corp. Announces Availability of Annual General Meeting Materials and Alternative Voting Procedures

MT Newswires

a year ago

BriaCell Therapeutics Raises $5.55 Million in an Underwritten Offering of Share Units

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $5.5 Million Public Offering

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell 2024 SABCS® Poster Highlights Ability of Bria-IMT™ Regimen to Increase Cancer-Fighting Immune Cells in Metastatic Breast Cancer

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Pricing of $5.5 Million Public Offering

MT Newswires

a year ago

BriaCell Therapeutics Plans Public Offering; Shares Plunge After Hours

BriaCell Therapeutics Announces Proposed Public Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Proposed Public Offering

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

GlobeNewswire

a year ago

BriaCell Presents Unprecedented Overall Survival Data in Metastatic Breast Cancer in Spotlight Poster at 2024 SABCS®

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell Receives Green-Light from Data Safety Monitoring Board for its Phase 3 Study in Metastatic Breast Cancer

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

GlobeNewswire

a year ago

BriaCell 2024 SABCS® Spotlight Poster to Showcase Positive Overall Survival Data Across All Patient Subtypes in Metastatic Breast Cancer

BriaCell Provides Update to its Board of Directors

GlobeNewswire

a year ago

BriaCell Provides Update to its Board of Directors

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

GlobeNewswire

a year ago

BriaCell Announces First Patient Dosed with Bria-OTS™ in Metastatic Breast Cancer Study

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

GlobeNewswire

a year ago

BriaCell Showcases Robust Anti-Cancer Activity of Personalized Off-the-Shelf Immunotherapy Pipeline at the 2024 SITC Conference

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

GlobeNewswire

a year ago

BriaCell Overall Survival Data Selected for Spotlight Poster at 2024 San Antonio Breast Cancer Symposium®, December 10 – 13

MT Newswires

a year ago

BriaCell Higher as it Reports "Standard-Beating" Survival Data From Phase 2 Study

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

GlobeNewswire

a year ago

BriaCell Reports Outperforming Metastatic Breast Cancer Patients and Standard-Beating Survival Data

MT Newswires

a year ago

BriaCell to Complete Patient Enrollment for Phase 3 Breast Cancer Study by Mid-2025; Shares Rise

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

GlobeNewswire

a year ago

BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study

MT Newswires

a year ago

BriaCell Therapeutics Closes Offering of 5.13 Million Shares, Warrants

BriaCell Therapeutics Announces Closing of $5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Shares Plummet After Pricing of $5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Down 41% as it Announces US$5-Million Share-Unit Offering

BriaCell Therapeutics Announces $5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces $5 Million Offering

MT Newswires

a year ago

BriaCell Reports 'Dramatic' Anti-tumor Response in Breast Cancer Patient in Phase 2 Study; Shares Up Pre-Bell

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

GlobeNewswire

a year ago

BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

Zacks

a year ago

What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock

MT Newswires

a year ago

BriaCell Says FDA Greenlit Expanded Access Policy for Metastatic Breast Cancer Patients

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

GlobeNewswire

a year ago

BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients

MT Newswires

a year ago

BriaCell Therapeutics Closes $8.5 Million Offering

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

GlobeNewswire

a year ago

BriaCell Therapeutics Announces Closing of $8.5 Million Offering

MT Newswires

a year ago

BriaCell Therapeutics Announces US$8.5 Million Share Offering

Share on Social Networks: